Aster DM's stock spurts ~11% as PAT jumps by a whopping 238% yoy in FY22

25 May 2022 , 11:21 AM

Aster DM Healthcare’s counter jumped nearly 12% in today’s trade after the company announced its results for the quarter and financial year ended March 31, 2022.

Company’s revenue from operations logged growth of 14% yoy at Rs2,728 crore in Q4FY22, as against Rs2,391 crore in Q4FY21. While revenue for FY22 jumped 19% yoy at Rs10,253 crore as against Rs8,608 crore in FY21.

EBITDA for FY22 jumped 40% yoy at Rs1,483 crore as compared to Rs1,063 crore in FY21. For Q4FY22, the company’s EBITDA increased 44% yoy at Rs463 crore as against Rs321 crore in Q4FY21.

PAT for Q4FY22 (Pre Non-Controlling Interest) increased to Rs246 crore, up 110% yoy as compared to Rs117 crore in the same period, the previous financial year.

PAT for FY22 increased significantly by 238% yoy at Rs601 crore as compared to Rs178 crore in FY21.

At around 11.18 AM, Aster DM’s counter was trading 10.83% or Rs18.70 higher at Rs191.40, as against the previous close of Rs172.70 on BSE. It opened at Rs184 and touched intraday high and low of Rs197.20 and Rs184 respectively so far.